Co-occurrence of Marfan syndrome and schizophrenia: What can be learned?

European Journal of Medical Genetics

Volumn 55, Issue 4, 2012, Pages 252-255

  Van Den Bossche, Maarten J A ^a,b   Van Wallendael, Kevin L P ^c   Strazisar, Mojca ^a,b   Sabbe, Bernard ^b,c   Del Favero, Jurgen ^a,b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c Psychiatric Hospital Sint Norbertus   (Belgium)

Author keywords

FBN1; Marfan syndrome; Schizophrenia; TGF

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; CLOZAPINE; FIBRILLIN 1; OLANZAPINE; PROLACTIN; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGGRESSION; ARACHNODACTYLY; ARTICLE; AUDITORY HALLUCINATION; CASE REPORT; DELUSION; DISEASE ASSOCIATION; DISORIENTATION; DRUG WITHDRAWAL; FEMALE; GENETIC ANALYSIS; HUMAN; HYPERACTIVITY; HYPERPROLACTINEMIA; MARFAN SYNDROME; NONSENSE MUTATION; PROLACTIN BLOOD LEVEL; PSYCHOSIS; SCHIZOPHRENIA; SIDE EFFECT;

CODON, NONSENSE; DNA MUTATIONAL ANALYSIS; FEMALE; GENOTYPE; HUMANS; MARFAN SYNDROME; MICROFILAMENT PROTEINS; PEDIGREE; PHENOTYPE; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84860382338     PISSN: 17697212     EISSN: 18780849     Source Type: Journal    
DOI: 10.1016/j.ejmg.2012.02.005     Document Type: Article

References (40)

1. Judge D.P., Dietz H.C. Marfan's syndrome. Lancet 2005, 366:1965-1976.
2. Boileau C., Jondeau G., Mizuguchi T., Matsumoto N. Molecular genetics of Marfan syndrome. Curr. Opin. Cardiol. 2005, 20:194-200.
3. Lichtenstein P., Yip B.H., Bjork C., Pawitan Y., Cannon T.D., Sullivan P.F., Hultman C.M. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 2009, 373:234-239.
4. Lindeboom G.A., Westerveld-Brandon E.R. Dilatation of the aorta in arachnodactyly. Cardiologia 1950, 17:217-222.
5. Romano J., Linares R.L. Marfan's syndrome and schizophrenia: a case report. Arch. Gen. Psychiatry 1987, 44:190-192.
6. Sirota P., Frydman M., Sirota L. Schizophrenia and Marfan syndrome. Br. J. Psychiatry 1990, 157:433-436.
7. Mercuro G., Carpiniello B., Ruscazio M., Zoncu S., Montisci R., Rudas N., Cherchi A. Association between psychiatric disorders and Marfan's syndrome in a large Sardinian family with a high prevalence of cardiac abnormalities. Clin. Cardiol. 1997, 20:243-245.
8. Rao N.P., Loganathan S., Prakash O., Varghese M. Use of electroconvulsive therapy for schizophrenia with comorbid Marfan syndrome. J. ECT 2009, 25:276-277.
9. Lemberg M., Thompson A.W. Marfan syndrome and schizophrenia: a case report and literature review. Gen. Hosp. Psychiatry 2010, 32:228.
10. Wechsler D. WAIS-IV. Wechsler Adult Intelligence Scale 2008, Psychological Corporation, San Antonio, TX. fourth ed.
11. M.B. First, R.L. Spitzer, M. Gibbon, J.B.W. Williams, Structured clinical interview for DSM-IV axis I disorders: research version: Non-patient edition (SCID-I/NP), Structured clinical interview for DSM-IV axis I disorders: research version: Non-patient edition (SCID-I/NP), 2002.
12. Lecrubier Y., Sheehan D.V., Weiller E., Amorim P., Bonora I., Harnett Sheehan K., Janavs J., Dunbar G.C. The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI. Eur. Psychiatry 1997, 12:224-231.
13. Beighton P., Horan F. Orthopaedic aspects of the Ehlers-Danlos syndrome. J. Bone Joint Surg. Br. 1969, 51:444-453.
14. Hung C.C., Lin S.Y., Lee C.N., Cheng H.Y., Lin C.Y., Chang C.H., Chiu H.H., Yu C.C., Lin S.P., Cheng W.F., Ho H.N., Niu D.M., Su Y.N. Identification of fibrillin-1 gene mutations in Marfan syndrome by high-resolution melting analysis. Anal. Biochem. 2009, 389:102-106.
15. Rozen S., Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol. Biol. 2000, 132:365-386.
16. Weckx S., Del-Favero J., Rademakers R., Claes L., Cruts M., De J.P., Van B.C., De R.P. novoSNP, a novel computational tool for sequence variation discovery. Genome Res. 2005, 15:436-442.
17. Swindell S.R., Plasterer T.N. SEQMAN. Contig assembly. Methods Mol. Biol. 1997, 70:75-89.
18. Loeys B.L., Dietz H.C., Braverman A.C., Callewaert B.L., De B.J., Devereux R.B., Hilhorst-Hofstee Y., Jondeau G., Faivre L., Milewicz D.M., Pyeritz R.E., Sponseller P.D., Wordsworth P., De Paepe A.M. The revised Ghent nosology for the Marfan syndrome. J. Med. Genet. 2010, 47:476-485.
19. Liu W.O., Oefner P.J., Qian C., Odom R.S., Francke U. Denaturing HPLC-identified novel FBN1 mutations, polymorphisms, and sequence variants in Marfan syndrome and related connective tissue disorders. Genet. Test. 1997, 1:237-242.
20. Hung C.C., Lin S.Y., Lee C.N., Cheng H.Y., Lin S.P., Chen M.R., Chen C.P., Chang C.H., Lin C.Y., Yu C.C., Chiu H.H., Cheng W.F., Ho H.N., Niu D.M., Su Y.N. Mutation spectrum of the fibrillin-1 (FBN1) gene in Taiwanese patients with Marfan syndrome. Ann. Hum. Genet. 2009, 73:559-567.
21. Ramensky V., Bork P., Sunyaev S. Human non-synonymous SNPs: server and survey. Nucleic Acids Res. 2002, 30:3894-3900.
22. Peters K.F., Kong F., Horne R., Francomano C.A., Biesecker B.B. Living with Marfan syndrome I. Perceptions of the condition. Clin. Genet. 2001, 60:273-282.
23. Hofman K.J., Bernhardt B.A., Pyeritz R.E. Marfan syndrome: neuropsychological aspects. Am. J. Med. Genet. 1988, 31:331-338.
24. Purandare K.N., Markar T.N. Psychiatric symptomatology of Lujan-Fryns syndrome: an X-linked syndrome displaying Marfanoid symptoms with autistic features, hyperactivity, shyness and schizophreniform symptoms. Psychiatr. Genet. 2005, 15:229-231.
25. Abbott M.H., Folstein S.E., Abbey H., Pyeritz R.E. Psychiatric manifestations of homocystinuria due to cystathionine beta-synthase deficiency: prevalence, natural history, and relationship to neurologic impairment and vitamin B6-responsiveness. Am. J. Med. Genet. 1987, 26:959-969.
26. Lalatta F., Livini E., Selicorni A., Briscioli V., Vita A., Lugo F., Zollino M., Gurrieri F., Neri G. X-linked mental retardation with marfanoid habitus: first report of four Italian patients. Am. J. Med. Genet. 1991, 38:228-232.
27. De H.M., Steemans D., Theys P., Fryns J.P., Peuskens J. Lujan-Fryns syndrome in the differential diagnosis of schizophrenia. Am. J. Med. Genet. 1996, 67:212-214.
28. Bracken P., Coll P. Homocystinuria and schizophrenia. Literature review and case report. J. Nerv. Ment. Dis. 1985, 173:51-55.
29. Ryan M.M., Sidhu R.K., Alexander J., Megerian J.T. Homocystinuria presenting as psychosis in an adolescent. J. Child Neurol. 2002, 17:859-860.
30. Kalsi G., Mankoo B.S., Brynjolfsson J., Curtis D., Read T., Murphy P., Sharma T., Petursson H., Gurling H.M. The Marfan syndrome gene locus as a favoured locus for susceptibility to schizophrenia. Psychiatr. Genet. 1994, 4:219-227.
31. Meyer J., Ortega G., Schraut K., Nurnberg G., Ruschendorf F., Saar K., Mossner R., Wienker T.F., Reis A., Stober G., Lesch K.P. Exclusion of the neuronal nicotinic acetylcholine receptor alpha7 subunit gene as a candidate for catatonic schizophrenia in a large family supporting the chromosome 15q13-22 locus. Mol. Psychiatry 2002, 7:220-223.
32. Leonhard K., Beckmann H. Classification of Endogenous Psychoses and Their Differential Etiology 1999, Springer Verlag, Wien.
33. Stober G., Saar K., Ruschendorf F., Meyer J., Nurnberg G., Jatzke S., Franzek E., Reis A., Lesch K.P., Wienker T.F., Beckmann H. Splitting schizophrenia: periodic catatonia-susceptibility locus on chromosome 15q15. Am. J. Hum. Genet. 2000, 67:1201-1207.
34. Stober G., Seelow D., Ruschendorf F., Ekici A., Beckmann H., Reis A. Periodic catatonia: confirmation of linkage to chromosome 15 and further evidence for genetic heterogeneity. Hum. Genet. 2002, 111:323-330.
35. Tsuang D.W., Skol A.D., Faraone S.V., Bingham S., Young K.A., Prabhudesai S., Haverstock S.L., Mena F., Menon A.S., Bisset D., Pepple J., Sauter F., Baldwin C., Weiss D., Collins J., Boehnke M., Schellenberg G.D., Tsuang M.T. Examination of genetic linkage of chromosome 15 to schizophrenia in a large Veterans Affairs Cooperative Study sample. Am. J. Med. Genet. 2001, 105:662-668.
36. Freedman R., Coon H., Myles-Worsley M., Orr-Urtreger A., Olincy A., Davis A., Polymeropoulos M., Holik J., Hopkins J., Hoff M., Rosenthal J., Waldo M.C., Reimherr F., Wender P., Yaw J., Young D.A., Breese C.R., Adams C., Patterson D., Adler L.E., Kruglyak L., Leonard S., Byerley W. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:587-592.
37. Djurovic S., Gustafsson O., Mattingsdal M., Athanasiu L., Bjella T., Tesli M., Agartz I., Lorentzen S., Melle I., Morken G., Andreassen O.A. A genome-wide association study of bipolar disorder in Norwegian individuals, followed by replication in Icelandic sample. J. Affect. Disord. 2010, 126:312-316.
38. Buckwalter M.S., Yamane M., Coleman B.S., Ormerod B.K., Chin J.T., Palmer T., Wyss-Coray T. Chronically increased transforming growth factor-beta1 strongly inhibits hippocampal neurogenesis in aged mice. Am. J. Pathol. 2006, 169:154-164.
39. Awasaki T., Huang Y., O'Connor M.B., Lee T. Glia instruct developmental neuronal remodeling through TGF-beta signaling. Nat. Neurosci. 2011, 14:821-823.
40. Pickard B. Progress in defining the biological causes of schizophrenia. Expert Rev. Mol. Med. 2011, 13:e25.